Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-108430
Filing Date
2024-09-20
Accepted
2024-09-20 16:30:56
Documents
1
Period of Report
2024-09-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4798
  Complete submission text file 0000950170-24-108430.txt   6316
Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Behbahani Ali (Reporting) CIK: 0001613867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 241313773

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)